S&P 500 Technology Sector SEC Filings — June 04, 2026

USA S&P 500 Technology

By Gunpowder Editorial ·

6 high priority 9 medium priority 15 total filings analysed

Executive Summary

The June 4 filing batch reveals a bipolar tech sector where high-growth companies like CrowdStrike, Planet Labs, and GameSquare are delivering outsized top-line gains (25-137% YoY) but face headwinds from rising costs, negative cash flow dynamics, or dilutive financing.

A dominant thematic is the convergence of activist/transaction-related filings—three Genco Shipping filings detail a hostile takeover battle, while Pasqal pursues a SPAC merger at a $2B valuation. Period-over-period data shows margin compression across multiple filers: CrowdStrike's subscription gross margin improved slightly (+120 bps YoY) but professional services margin deteriorated, while Planet Labs' non-GAAP gross margin is guiding down 300-700 bps QoQ. Insider trading activity is notably absent from these filings, but capital allocation signals are rich—CrowdStrike repurchased $175.6M in shares and spent $881.4M on acquisitions, while Planet Labs redeemed warrants for $108M. Sentiment is mixed across the portfolio with 7 mixed, 4 neutral, 2 negative, and 1 positive filings (Imunon), and the average materiality score of 6.7/10 indicates high relevance for investors.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: DEFA14A · 10-Q · 8-K · Schedule 13D · 425

Tracking the trend? Catch up on the prior S&P 500 Technology Sector SEC Filings digest from June 03, 2026.

Investment Signals (8)

  • Net income swing from -$104.3M to +$27.8M YoY (turnaround), subscription revenue +25.6% YoY to $1.39B, share repurchases of $175.6M signal confidence

  • Subscription gross margin improved to 78.2% from 77.0% YoY (+120 bps), but stock-based compensation surged to $297.7M (up 20% YoY), diluting shareholders

  • Record Q1 revenue of $94.2M (+42% YoY), backlog +72% to $906M, positive operating cash flow of $15.4M (vs $1.9M prior year) despite GAAP loss; strong forward guidance of Q2 rev $102-107M

  • Projected Q2 2026 revenue ≥$18.5M (+137% YoY, +27% sequential), FY26 guidance $85-90M with >$5M adjusted EBITDA; creator deployment revenue in H1 expected ~$5M vs $5.4M in all of 2025 signaling deceleration in that segment

  • Imunon (BULLISH)

    $10M financing with no warrants (accretive structure), Phase 3 OVATION 3 trial fully funded, Phase 2 OS improvement from 11.1 to 14.7 months; PARP combo showed 24.2-month OS benefit vs SOC

  • Pasqal (MIXED)

    SPAC merger at $2B pre-money with $250M committed convertible financing, backlog of EUR 66M ($76.5M), roadmap to fault-tolerant quantum by 2029; no current-period P&L disclosed creates execution risk

  • Net loss of -$147.6M in Q1 2026 vs +$19.7M in Q1 2025 driven by $148.6M unrealized loss on HHH; but operating cash flow +35.1% YoY to $87.9M and performance fees of $497.3M fully collected

  • Board fighting hostile $24.80/share offer from Diana, currently trading at discount to mean NAV ($26.66) and median NAV ($27.10), dividend streak of 27 consecutive quarters ($7.16/share total) [BULLISH for long-term holders]

Risk Flags (9)

  • CrowdStrike Cash Flow Risk [HIGH RISK]

    Operating cash flow negative from deferred revenue changes (-$36.7M), cash and equivalents fell 12.9% to $4.55B despite revenue growth, driven by $881.4M M&A spend

  • CrowdStrike SBC Dilution Risk [MEDIUM RISK]

    Stock-based compensation of $297.7M equals ~107% of net income, a classic tech overhang; SBC grew 20% YoY vs revenue growth 25.6%

  • Planet Labs Margin Compression Risk [HIGH RISK]

    Q2 FY27 non-GAAP gross margin guided to 52-55% vs Q1 FY27 actual of 56% and Q1 FY26 actual of 59%—a decline of 400-700 bps YoY, signaling pricing pressure or mix shift

  • Planet Labs Earnings Quality Risk [MEDIUM RISK]

    GAAP net loss widened to -$138.9M from -$12.6M YoY, driven by non-cash warrant revaluation loss of ~$106.5M; adjusted EBITDA slipped to -$1.0M from +$1.2M, indicating core operating deterioration

  • GameSquare Creator Revenue Deceleration Risk [MEDIUM RISK]

    Creator deployment revenue in H1 2026 expected ~$5M vs $5.4M in all of 2025, implying potential annualized decline despite overall revenue growing 137%—suggests concentration shift or competitive loss in that sub-segment

  • Annual meeting June 18 with six Diana nominees proposed, poison pill adopted without shareholder approval, Diana's offer 1.0x NAV vs 82% average for comparable take-private deals; shares traded at 30% discount to NAV since 2020

  • Pershing Square Unrealized Loss Risk [MEDIUM RISK]

    $148.6M unrealized loss on HHH investment drove net loss, total assets fell 41.8% from $1.7B to $990.5M, concentrated single-name exposure persists

  • Imunon Financing Risk [MEDIUM RISK]

    $7.72M in secured promissory notes at 8% and 5% interest with 18-month maturity creates fixed-cost burden; Phase 3 trial (500 patients) may need additional capital before completion

  • Pasqal SPAC Execution Risk [HIGH RISK]

    No current financial results disclosed, backlog-to-revenue conversion uncertain, quantum computing remains early-stage commercial; SPAC merger second half 2026 completion

Opportunities (7)

  • From -$104.3M loss to +$27.8M profit YoY, subscription gross margin improving to 78.2%, $4.55B cash base despite M&A spend; look for operating leverage as SBC stabilizes

  • Backlog up 72% to $906M vs revenue run-rate ~$400M, providing 2.25x visibility; positive operating cash flow recently achieved; Q2 revenue guidance midpoint $104.5M (+11% QoQ)

  • 137% YoY growth, 60% of revenue in H2, 14x revenue growth since Q1 2024, 3x client base growth; if FY26 guidance achieved ($85-90M), shares should re-rate, especially if EBITDA-positive ($5M+)

  • Fully financed Phase 3 (OVATION 3) with 500 patients, two interim analyses for early registration; updated Phase 2 OS of 14.7 months (vs 11.1 prior) and PARP combo OS 24.2 months—best-in-class ovarian cancer data

  • Shares trading below mean analyst NAV of $26.66 and below Diana's $24.80 offer; if proxy fight fails and poison pill stands, buyout may need to increase—or existing dividend yield ($7.16/share cumulative) supports value

  • SPAC merger at $2B pre-money with $250M committed convertible, partnerships with Google/Microsoft, backlog EUR 66M; if fault-tolerant quantum roadmap by 2029 succeeds, early investors benefit from frontier tech

  • Strong operating cash flow of $87.9M (+35% YoY), performance fees fully collected ($497.3M), loans payable stable at $34.8M; net loss driven by unrealized marks, not operational issues; capital distributions to partners increased

Sector Themes (6)

  • Revenue Growth Acceleration Across Tech

    CrowdStrike (+25.6%), Planet Labs (+42%), and GameSquare (+137%) all delivered well above S&P 500 average—demonstrating that enterprise and space-tech demand remains robust despite macro concerns

  • Margin Divergence: Subscription vs Services

    CrowdStrike's subscription margin improved (+120 bps YoY) while professional services margin compressed (-470 bps), highlighting the profitability advantage of recurring SaaS models over consulting-style revenue

  • M&A and Activism Intensity

    4 of 15 filings (Genco/Diana battle, Pasqal SPAC, BNY Mellon proxies, United Community Banks merger) involve restructuring or combative M&A, suggesting elevated deal activity and management distraction risk

  • Cash Flow vs GAAP Earnings Disconnect

    Both CrowdStrike and Planet Labs show strong revenue growth but have GAAP losses or negative cash flow from operations adjustments, underscoring the importance of cash-based metrics for tech investors

  • Non-cash Charges Distorting Real Performance

    Planet Labs' -$138.9M loss driven by warrant revaluation, Pershing Square's -$147.6M loss from unrealized investment marks—investors must look through one-time items to operating realities

  • Capital Allocation Choices: Buybacks vs M&A

    CrowdStrike spent $175.6M on buybacks but $881.4M on M&A (5x ratio), Planet Labs redeemed warrants ($108M), Pershing Square distributed $90.6M to partners—companies prioritizing investment and shareholder returns over cash hoarding

Watch List (8)

  • Watch for any sequential subscription revenue deceleration, FCF conversion trends, and SBC ratio; next earnings call likely mid-August for Q2 FY26 results

  • Scheduled June 18, 2026—critical vote on Diana Shipping nominees; if Diana wins board seats, tender offer could be raised; if Genco wins, stock may test NAV discount

  • June 26, 2026 deadline for Diana's $24.80/share tender offer; watch for any extension or price increase if too few shares tendered

  • Due ~September 2026; key metrics: revenue guidance $102-107M, non-GAAP gross margin 52-55% (down from 56% in Q1), adjusted EBITDA target $0-5M—margin compression trajectory critical

  • Monitoring first patient dosed and timing of interim analyses; additional financing may be needed given $2.5M preferred + $7.72M notes vs Phase 3 cost

  • Expected second half 2026; watch for SEC effectiveness, shareholder vote, and any updated financial projections including backlog-to-revenue conversion

  • Legal close expected Q3 2026, systems conversion Feb 2027; watch for regulatory approvals and any integration risk disclosure in subsequent filings

  • Expected ~August 2026; key metrics: HHH fair value changes, fee revenues, management fee growth, and any new capital allocation initiatives

Filing Analyses (15)
BNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC. DEFA14A neutral materiality 3/10

04-06-2026

BNY Mellon Strategic Municipal Bond Fund, Inc. filed additional definitive proxy soliciting materials on June 4, 2026, related to a shareholder meeting. The filing includes a graphic image but no specific financial data or material changes.

GENCO SHIPPING & TRADING LTD DEFA14A mixed materiality 9/10

04-06-2026

Genco Shipping & Trading Limited (GNK) sent a letter to shareholders urging them to vote for its board nominees and reject Diana Shipping Inc.'s inadequate $24.80 per share tender offer, which is below Genco's mean analyst NAV estimate of $26.66 and median estimate of $27.10. The company highlights its Comprehensive Value Strategy, which has delivered $7.16 per share in dividends over 27 consecutive quarters, the longest uninterrupted period in the industry. However, Diana's nominees include individuals with records of bankruptcy and shareholder value destruction, and Diana's CEO could personally benefit from a potential acquisition via sale and purchase fees.

  • · Genco's annual meeting is scheduled for June 18, 2026.
  • · Diana's offer is at a discount to Genco's liquidation value and lacks a control premium.
  • · Diana's CEO may receive millions in sale and purchase fees from a potential Genco acquisition via an affiliated entity.
  • · Genco's board is majority independent and highly qualified; Diana's nominees include individuals with ties to Diana and records of bankruptcy or shareholder value destruction.
  • · Genco's stock price has trended in line with peers since Diana's initial offer, not affected by the offers.
  • · Genco is open to meeting with Diana if they submit a proposal reflecting underlying asset value with an appropriate control premium.
GENCO SHIPPING & TRADING LTD SC 14D9/A negative materiality 9/10

04-06-2026

Genco Shipping & Trading Limited (GNK) issued a letter to shareholders opposing Diana Shipping's inadequate $24.80 per share tender offer and proxy fight to replace Genco's board. Genco highlights its Comprehensive Value Strategy, which has delivered $7.16 per share in dividends over 27 consecutive quarters, and notes that Diana's offer is below the mean analyst NAV estimate of $26.66 and median of $27.10. Genco recommends shareholders not tender shares and vote for its nominees, while warning that Diana's nominees have ties to bankruptcy and value destruction.

  • · Genco's annual meeting is scheduled for June 18, 2026.
  • · Diana's offer is below liquidation value and lacks a control premium.
  • · Genco's board is majority independent and highly qualified.
  • · Diana's CEO may personally benefit from a potential acquisition via sale and purchase fees to an affiliated entity.
  • · Diana's nominees include individuals with ties to bankruptcy (Sterling Shipping, Bulk Invest) and shareholder value destruction (Statt Torsk).
  • · Genco is ranked in the industry's top quartile for corporate governance, while Diana is in the third quartile.
CrowdStrike Holdings, Inc. 10-Q mixed materiality 9/10

04-06-2026

CrowdStrike reported a net income of $27.8M for Q1 FY26, a significant turnaround from a net loss of $104.3M in Q1 FY25. Total revenue grew 25.6% YoY to $1.39B, driven by subscription revenue growth of 25.7%. However, the company generated negative operating cash flow from changes in deferred revenue, which declined $36.7M, and cash and cash equivalents fell 12.9% from January 2026 to $4.55B, partly due to $881.4M in acquisition spending and $175.6M in share repurchases.

  • · Subscription gross margin improved to 78.2% in Q1 FY26 from 77.0% in Q1 FY25.
  • · Professional services gross margin declined to 16.9% in Q1 FY26 from 11.7% in Q1 FY25.
  • · Stock-based compensation expense was $297.7M in Q1 FY26, up from $247.7M in Q1 FY25.
  • · The company repurchased 480,000 shares for $175.6M during Q1 FY26.
  • · Goodwill increased 66.3% to $2.27B due to acquisitions.
  • · Deferred revenue (current) declined 1.5% sequentially to $3.37B.
  • · Cash used in investing activities was $994.1M, primarily for acquisitions.
  • · Net cash provided by operating activities increased 53.8% YoY to $590.9M.
BNY MELLON STRATEGIC MUNICIPALS, INC. DEFA14A neutral materiality 2/10

04-06-2026

BNY MELLON STRATEGIC MUNICIPALS, INC. filed a DEFA14A (additional proxy material) on June 4, 2026, related to a shareholder meeting. The filing supplements previously issued proxy materials, but no specific financial figures, voting results, or material changes were disclosed in the available content. The filing appears to be procedural in nature, with no new substantive proposals or financial data provided.

  • · The filing is a DEFA14A (additional proxy soliciting materials) filed under the Securities Exchange Act of 1934.
  • · The company was formerly named DREYFUS STRATEGIC MUNICIPALS, INC. and changed its name on October 30, 2018.
  • · No financial results, voting outcomes, or new business proposals are included in the supplied portion of the filing.
Planet Labs PBC 8-K mixed materiality 9/10

04-06-2026

Planet Labs PBC reported record Q1 FY27 revenue of $94.2M, up 42% YoY, and backlog grew 72% YoY to over $906M. However, GAAP net loss widened sharply to ($138.9M) from ($12.6M) in the prior year, driven by a (~$106.5M) non-cash warrant revaluation loss, while adjusted EBITDA slipped to a ($1.0M) loss from $1.2M profit a year ago. The company ended the quarter with $730.8M in cash after redeeming public warrants for ~$108M in proceeds, and guided Q2 FY27 revenue of $102M-$107M with expected adjusted EBITDA profitability of $0-$5M.

  • · Net cash provided by operating activities was $15.4M in Q1 FY27, a positive operating cash flow quarter.
  • · GAAP net loss per share was ($0.40), with ($0.31) attributable to the non-cash warrant revaluation loss.
  • · Non-GAAP gross margin guidance for Q2 FY27 is 52%-55%, down from 56% in Q1 FY27 and 59% in Q1 FY26.
  • · Capital expenditure guidance for Q2 FY27 is ~$21M-$27M, and for full FY27 is ~$80M-$95M.
  • · Adjusted EBITDA guidance for Q2 FY27 is $0-$5M profit, and for full FY27 is $0-$10M profit.
  • · The company redeemed all outstanding public warrants and all remaining private placement warrants were exercised on a cashless basis, eliminating future warrant revaluation impacts.
  • · During the quarter, Planet signed an eight-figure, one-year contract with an international Defense & Intelligence customer.
  • · The NGA awarded a $21.9M one-year contract extension for maritime surveillance under Luno B AAMOR program, plus a new award for Global Monitoring Service.
  • · U.S. Navy awarded a six-month, $7.5M contract renewal for vessel detection in the Pacific.
  • · Greek government signed a two-year, 7-figure agreement via ESA for the National Satellite Space Project.
  • · Czech Paying Agency (SZIF) signed a two-year, 7-figure contract for agricultural monitoring covering ~25,000 agricultural holdings.
  • · Scottish Government awarded a 7-figure contract with Computacenter for agricultural transition support.
  • · John Deere gave Planet a Supplier Sustainability Award for 2025.
  • · Nave Analytics renewed partnership incorporating Planetary Variables since 2022.
  • · Watch Duty (non-profit wildfire tracking) became a new customer integrating Planet imagery.
  • · The Pelican-11 satellite (first Gen-2 Pelican, targeting up to 30cm-class imagery) was shipped for launch on Transporter-17 with SpaceX.
  • · Swedish Armed Forces launched its first sovereign reconnaissance satellite on the Pelican mission, just over 4 months after contract signing.
GameSquare Holdings, Inc. 8-K neutral materiality 4/10

04-06-2026

GameSquare Holdings, Inc. issued a press release letter to shareholders on June 4, 2026, announcing an update on various business matters. The filing is furnished under Item 7.01 (Regulation FD) and does not provide specific financial figures or detailed operational metrics in the main 8-K body.

  • · The press release was issued on June 4, 2026, and is furnished as Exhibit 99.1 to this 8-K filing.
  • · The filing is intended to satisfy Regulation FD disclosure obligations and is not deemed filed for Exchange Act Section 18 purposes.
  • · The registrant is an emerging growth company and has not elected the extended transition period for complying with new or revised financial accounting standards.
GameSquare Holdings, Inc. DEFA14A mixed materiality 8/10

04-06-2026

GameSquare Holdings issued a shareholder letter projecting strong Q2 2026 revenue of at least $18.5 million, representing over 137% YoY growth and over 27% sequential growth from Q1 2026. The company also expects first-half 2026 proforma revenue of over $34.3 million (up at least 125% YoY) and reiterated full-year 2026 guidance of $85M-$90M proforma revenue, 35%-40% gross margin, and over $5M adjusted EBITDA. However, the company acknowledges its share price has not yet reflected the value being built, and the letter is part of soliciting shareholder votes for governance resolutions.

  • · Approximately 60% of revenue historically occurs in the second half of the year.
  • · Creator deployment revenue in H1 2026 expected to be ~$5M, compared to $5.4M in all of 2025 (a decline on an annualized basis).
  • · GSX has increased its recurring client base by over 3x and grown revenue by approximately 14x since Q1 2024.
  • · The company expects to launch new AI-enabled tools (Creative Communities) later in 2026.
  • · International revenue currently represents about 25% of total revenue.
  • · The 2026 Esports World Cup will take place July–August in Paris, France with a $75M prize pool.
  • · Full Q2 2026 results expected to be reported in mid-August 2026.
PERSHING SQUARE HOLDCO, L.P. 8-K neutral materiality 5/10

04-06-2026

Pershing Square Inc. announced the availability of its financial supplement for Q1 2026 and April 2026, including key operating metrics and non-GAAP measures. The filing provides incremental monthly data due to the completion of the IPO of Pershing Square USA, Ltd. and the listing of PS common stock on the NYSE on April 30, 2026. No specific financial figures are disclosed in the 8-K.

  • · The financial supplement includes fee-related earnings and distributable earnings, which are non-GAAP measures.
  • · The Company intends to disclose financial supplements for completed fiscal periods only going forward.
  • · The IPO of Pershing Square USA, Ltd. and the distribution and public listing of PS common stock closed on April 30, 2026.
PERSHING SQUARE HOLDCO, L.P. 10-Q mixed materiality 9/10

04-06-2026

Pershing Square Holdco, L.P. reported a net loss attributable to the firm of $147.6M for Q1 2026, compared to net income of $19.7M in Q1 2025, driven primarily by a $148.6M unrealized loss on its investment in Howard Hughes Holdings Inc. (HHH). Total revenue increased 10.0% to $57.5M, driven by higher management fees, while operating income fell 51.2% to $5.1M due to a sharp rise in general and administrative expenses. Total assets declined 41.8% to $990.5M from $1.7B at year-end 2025, largely reflecting the HHH fair value drop and the collection of performance fees receivable.

  • · Performance fees receivable of $497.3M at Dec 31, 2025 were fully collected by March 31, 2026, contributing to strong operating cash flow of $87.9M in Q1 2026 (up 35.1% YoY).
  • · Loans payable remained unchanged at $34.8M.
  • · Capital distributions to partners totaled $90.6M in Q1 2026, up from $88.5M in Q1 2025.
  • · Offering costs for Pershing Square USA, Ltd. were $5.9M in Q1 2026 vs $0.6M in Q1 2025.
  • · Deferred HHH Services Agreement premium amortization of $3.7M was recorded as contra-revenue in Q1 2026 (none in Q1 2025).
  • · The investment in Pershing Square, L.P. at fair value declined 31.1% from $79.3M to $54.7M during Q1 2026.
  • · Accrued compensation and benefits dropped sharply from $426.1M at Dec 31, 2025 to $15.4M at Mar 31, 2026, reflecting payout of prior-year bonuses.
  • · Performance fee distributions payable decreased from $54.8M to $10.7M over the same period.
  • · Cash and cash equivalents and restricted cash fell to $47.0M at Mar 31, 2026 from $940.9M at Mar 31, 2025, primarily due to capital distributions and operating cash outflows in prior periods.
GENCO SHIPPING & TRADING LTD SC 13D/A mixed materiality 9/10

04-06-2026

On June 4, 2026, Diana Shipping Inc. (DSX) filed an amended SC 13D/A disclosing the extension of its hostile cash tender offer to acquire all outstanding shares of Genco Shipping & Trading Ltd (GNK) at $24.80 per share. The offer, made through its wholly-owned subsidiary 4 Dragon Merger Sub Inc., represents approximately 1.0x NAV based on VesselsValue broker valuations that Genco itself used for over five years. However, Genco has rejected the offer, adopting a new valuation methodology that inflates its NAV and demanding an additional control premium, while Diana notes that Genco shares have traded at an average 30% discount to NAV since 2020 and comparable take-private transactions have closed at an average of only 82% of NAV. Diana urges shareholders to vote for its six independent nominees at the June 18 annual meeting and to tender shares by the June 26 offer expiration.

  • · Genco adopted a poison pill (shareholder rights plan) on October 1, 2025, without shareholder approval, and has amended it multiple times without approval.
  • · Genco's tender offer expires at 5:00 p.m. New York City time on June 26, 2026, unless extended.
  • · Genco's annual meeting is scheduled for June 18, 2026, where Diana is proposing six independent nominees.
  • · Diana offers to be bound by an independent valuation process involving three brokers (each party selects one, plus a mutually agreed third).
  • · Genco's demand for a control premium on top of NAV is described as inconsistent with historical trading of shipping companies (average 30% discount to NAV since 2020).
  • · Diana notes Genco's newly adopted 'retention plan' would incur massive severance expense upon liquidation, which Genco excludes from its NAV calculations.
  • · The offer is fully financed and all-cash.
  • · Diana has filed multiple amendments to its Schedule TO (this is Amendment No. 9).
Pasqal Holding SAS 425 mixed materiality 8/10

04-06-2026

Pasqal Holding SAS, a French quantum computing company, plans to pursue technology and commercial acquisitions following its planned Nasdaq listing via a merger with SPAC Bleichroeder Acquisition Corp II, expected to close in the second half of 2026. The transaction values Pasqal at $2B pre-money, and the company has disclosed a backlog of EUR 66M ($76.5M) and $250M of committed convertible financing. While the company highlights strong commercial adoption (e.g., Saudi Aramco deployment) and a clear roadmap to fault-tolerant quantum computing by 2029, it faces the challenge of converting its significant backlog into revenue and has not yet provided current-period financial results or profitability metrics.

  • · Pasqal has two facilities: one in France and one in Canada to serve the North American market.
  • · The company offers both on-premise deployments and cloud access through partnerships with Google and Microsoft.
  • · Pasqal focuses on key verticals including energy, financial services, and specialty materials.
  • · The company's Form F-4 registration statement was publicly filed on 26 May 2026.
  • · Pasqal was founded in 2019 out of the Institut d'Optique.
  • · The company has already completed multiple acquisitions, including AEPONYX in 2025.
Imunon, Inc. 8-K positive materiality 8/10

04-06-2026

IMUNON announced a $10 million cash financing consisting of $2.5 million from preferred stock and $7.72 million from secured promissory notes (8% and 5% interest, 18-month maturity). The funds will support the Phase 3 OVATION 3 trial for IMNN-001 in advanced ovarian cancer. Updated Phase 2 data showed median overall survival improved from 11.1 to 14.7 months, and PARP inhibitor combination yielded a 24.2-month OS benefit versus standard of care.

  • · The financing includes no warrants, reducing dilution for existing shareholders.
  • · Interest on promissory notes will be partially offset by interest earned via bank deposit.
  • · Phase 3 OVATION 3 will enroll 500 patients randomized 1:1, with two interim analyses for potential early registration.
  • · Phase 2 OVATION 2 was not powered for statistical significance.
  • · Epithelial ovarian cancer has a 75% recurrence rate for stage III/IV and five-year survival rates of 41% (stage III) and 20% (stage IV).
  • · IMUNON has completed dosing in a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
AIM ImmunoTech Inc. 8-K neutral materiality 3/10

04-06-2026

AIM ImmunoTech Inc. announced on June 4, 2026 the release of a video presentation and investor deck detailing pre-clinical findings for Ampligen® (rintatolimod) as a potential prophylactic and early-onset antiviral treatment for Ebola virus disease (EVD). The materials are available on the Virtual Investor site and the company's website. The filing includes standard forward-looking statements and risk disclaimers regarding clinical development and regulatory approval.

  • · The video presentation is titled 'What This Means' and is available at https://virtualinvestorco.com/aim
  • · An investor presentation slide deck on EVD research is posted at https://aimimmuno.com/presentations
  • · The disclosure is furnished under Item 7.01 (Regulation FD) and shall not be deemed 'filed' under the Exchange Act
UNITED COMMUNITY BANKS INC 425 neutral materiality 5/10

04-06-2026

United Community Banks Inc. (UCB) announced a merger agreement with Peach State Bancshares, Inc., with a legal close expected in Q3 2026 subject to regulatory approval and a systems conversion scheduled for February 12–16, 2027. The filing also highlights employee initiatives like the 'Power of U' advisory council and introduces Mitch Ralston as Hall County President)Skip. No financial figures or performance metrics are provided in this communication.

  • · Legal close of merger expected in Q3 2026, subject to regulatory approval.
  • · Systems conversion scheduled for February 12–16, 2027.
  • · Mitch Ralston has over 40 years of banking experience and joined United in 2005.
  • · Power of U council meets quarterly and focuses on belonging, work experience, talent, benefits, life management, rewards and recognition.
  • · United Community Bank operates across six states.

Get daily alerts with 8 investment signals, 9 risk alerts, 7 opportunities and full AI analysis of all 15 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: S&P 500 Technology Sector SEC Filings

🇺🇸 More from United States

View all →